​

Funding Round

Series A - Glympse Bio

Series A - Glympse Bio

Investment Firm

Overview

Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.

Announced Date

Oct 09, 2018

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Polaris Partners

Polaris Partners

Polaris Partners is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

9

Investor Name
Participant InvestorGreatPoint Ventures
Participant InvestorGilead Sciences
Participant InvestorCRV
Participant InvestorARCH Venture Partners
Participant InvestorPolaris Partners

Round Details and Background

Glympse Bio raised $22000000 on 2018-10-09 in Series A

Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 09, 2018
Series A - Glympse Bio
9-22.0M
Dec 01, 2015
Seed Round - Glympse Bio
2-6.6M
Jul 15, 2020
Series B - Glympse Bio
12-46.7M
Dec 17, 2021
Venture Round - Glympse Bio
-18.0M

Recent Activity

There is no recent news or activity for this profile.